Experts and Officials Debate on "New Tobacco - Manage or Ban"

Industry Insight by 2FIRSTS.ai
May.21.2024
Experts and Officials Debate on "New Tobacco - Manage or Ban"
Experts and officials debated the import, production, and distribution of heated tobacco products at a forum on May 20.

According to a report from VIETTimes on May 20, experts and officials discussed various aspects of the importation, production, and distribution of heated tobacco products at a forum titled "New Tobacco- Manage or Ban." The majority of experts and participants do not agree with the Ministry of Industry's suggestion to provide pilot permits for these kinds of cigarettes, citing concerns about the potential impact on human health, particularly among the younger generation.

 

Angela Pratt, representative of the World Health Organization in Vietnam, highlighted the significant health impact of new nicotine and tobacco products, including e-cigarettes and heated tobacco. The smoke produced by these products contains various toxic substances, which may lead to cancer, heart disease, and other chronic lung diseases. Furthermore, she warned that there is a risk of battery explosions in these products, which could result in serious injuries to users.

 

She pointed out that these products often attract young people to try them through appealing packaging and product design, as well as using enticing flavors. These targeted marketing strategies pose a serious risk to young people becoming new nicotine addicts.

 

Dr. Angela told reporters that worldwide experience indicates it is difficult to effectively regulate these products because manufacturers constantly change them to evade regulations. This includes altering nicotine content, chemicals used, battery power, and flavors. For these reasons, the World Health Organization believes that a total ban on these products is the only choice that aligns with the Vietnamese government's priority of protecting public health, as well as with Central Committee Resolution No. 20, which emphasizes that "health is the most valuable asset of every citizen and society as a whole.

 

Dr. Angela emphasized the importance of recognizing that heated tobacco contains toxic substances similar to those found in regular cigarettes. Therefore, no matter how the tobacco industry distorts facts, there is no reason to believe that they would cause less harm to human health.

 

Dr. Angela believes that if the serious health risks of this type of tobacco were known before regular cigarettes became widely available on the commercial market, they would not have been legalized. No other legal, commercial product would be allowed to cause disease and premature death in over 50% of its users when used correctly.

 

In addition, similar to e-cigarettes, these heated tobacco products are becoming increasingly complex in design and flavor. Recently, there have also been some hybrid heated tobacco products emerging, which contain not only tobacco fibers but also nicotine solution found in e-cigarettes.

 

Dr. Angela, when asked about representing the World Health Organization in Vietnam and whether the research data presented by the Ministry of Health is compelling, as well as whether the Ministry of Health has been diligent in policy making, stated that the World Health Organization has closely collaborated with the Ministry of Health and other partners to review evidence regarding the health risks of these new products and international experiences in regulating them. The reports submitted by the Ministry of Health to the parliament have been reviewed, and it is believed that the reports have effectively summarized the latest and most compelling scientific evidence regarding the risks of these products, as well as international experiences.

 

Dr. Angela added that the Ministry of Health has been actively collaborating with other departments and partners to disseminate the undeniable harms of these products to the public, especially to young people who are targeted by the tobacco industry through incorrect marketing and misleading tactics. Therefore, the Ministry of Health has done everything possible to inform and educate the public about the dangers of these products. However, mere information and education are not enough. In order to effectively protect Vietnamese society, particularly young people, from the health risks posed by these products, we need Congress to pass a resolution or law to comprehensively ban these harmful products.

 

When asked about the success of countries in implementing regulations to effectively manage new forms of tobacco, Dr. Angela stated that based on the experiences of other countries, even nations with strong regulatory and enforcement capabilities like the United States, the United Kingdom, and Australia have been unable to prevent the use of these products by young people, the harms they pose to youth, and the rapid growth in usage rates. She specifically highlighted the diversity in design, style, and composition of new tobacco products like e-cigarettes, making it very challenging to effectively regulate these products once they are legalized.

 

Dr. Angela, a representative from the World Health Organization, mentioned that approximately 40 countries have now banned e-cigarettes, with 18 countries also banning heated tobacco products due to concerns about their health risks and difficulties in regulation. In the ASEAN region, four countries including Thailand, Singapore, Laos, and Cambodia have banned both products, while Brunei has banned e-cigarettes.

 

The Ministry of Health needs to start developing comprehensive legislative proposals, including amending the Anti-Smoking Harm Law to prohibit e-cigarettes, other nicotine products (including nicotine-free e-cigarettes), and heated tobacco products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
UK HMRC Unveils Red and Yellow Transitional Vape Duty Stamps Ahead of October Tax Launch
UK HMRC Unveils Red and Yellow Transitional Vape Duty Stamps Ahead of October Tax Launch
HM Revenue & Customs (HMRC) has released sample images of the UK’s transitional vaping duty stamps, showing red and yellow versions ahead of the new Vaping Products Duty and Vaping Duty Stamps Scheme starting on October 1, 2026. Transitional stamps contain physical security features but no digital scanning function. Approved businesses may purchase them through November 30 and affix them through December 31. HMRC has not stated that the red and yellow samples represent different product categories or tax statuses.
Regulations
Sep.02
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei Industrial Co., Ltd. disclosed several oral nicotine-related patent applications in August 2026, including two that approach staged nicotine release from different directions. One uses a high-viscosity membrane that forms inside the pouch after contact with saliva to slow rapid early release, while the other uses gradient particles with a faster-disintegrating outer layer and a slower core to create a fast-to-sustained release profile. Together, the filings explore how nicotine pouches could balance initial delivery with release later in use.
Sep.03
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07